New agreement to develop E. coli vaccine
The Roslin Institute has signed an agreement with Roslin Technologies, Scotland’s Rural College and Moredun Research Institute, to fund the commercial development of an E. coli O157:H7 vaccine for cattle to prevent life-threatening illnesses in people.
Scientists at Roslin and Moredun have provided the fundamental research behind the feasibility of a vaccination approach. They are now working closely with Dr Simon Wheeler of Roslin Technologies who are progressing the commercial development phase of the vaccine.
For the full article, please see here: